Trending
Prev Story
Next Story

Biotech News | Read the latest health news on TechCrunch

TechCrunch •
October 13, 2026 • 11:13 PM
1
1 reads 0 reactions

Read the latest news about biotech and health, from the most recent health tech and medical devices to research in synthetic biology and genetics.

Biotech News | Read the latest health news on TechCrunch

Read the latest news about biotech and health, from the latest health tech and medical devices to research in synthetic biology and genetics. Our biotech coverage has startups and research from around the world in context with industry and investment trends.

Get 50% off a second pass The Disrupt experience is meant to be shared. Get your pass and bring a colleague, partner, or peer at 50% off. Cover more ground by making connections, building momentum, and discovering what’s next in the startup ecosystem.

This AI startup says it can generate permit-ready blueprints in minutes

Elon Musk intensifies attack on Ambani over Starlink India launch delay

Remember Orkut? Its founder wants to bring it back

US bars Microsoft, Adobe, and major IT firms from green card program for skilled foreign workers

Elon Musk questions Ambani’s influence as Starlink India launch stalls

Cal AI’s 19-year-old founder just raised $10M for his new AI startup

Google releases a new local-first Granola competitor

Prev Swipe Story Next

Same Story from Other Publications

Compare how 3 other independent news outlets reported on this story.

3 Publications
The Next Web (TNW)
4d ago
Dundee biotech PhaSER wins $2.7M Gates grant for infectious disease drugs

Dundee biotech PhaSER wins $2.7M Gates grant for infectious disease drugs

PhaSER Biomedical has a two-year, $2.7m Gates Foundation grant to give global health researchers access to its humanised 8HUM mouse model.

#biotech
Compare →
CNBC World
1w ago
A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled

A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled

Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.

#biotech
Compare →
The Australian Financial Review (AFR)
2w ago
Labor in fresh budget fight as Greens back biotech sector

Labor in fresh budget fight as Greens back biotech sector

The Greens want greater the government to further relax its R&D tax concessions limits which critics say are a threat to innovation.

#biotech
Compare →

Related Stories

Technology
Build #2611